SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000891618-03-002612
Filing Date
2003-05-15
Accepted
2003-05-15 17:30:43
Documents
4
Period of Report
2003-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f90137e10vq.htm 10-Q 221489
3 EXHIBIT 10.36 f90137exv10w36.txt EX-10.36 24427
4 EXHIBIT 10.37 f90137exv10w37.txt EX-10.37 24437
5 EXHIBIT 99.1 f90137exv99w1.txt EX-99.1 2519
  Complete submission text file 0000891618-03-002612.txt   274705
Mailing Address 3832 BAY CENTER PLACE HAYWARD CA 94545
Business Address 3832 BAY CENTER PL HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Filer) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22570 | Film No.: 03706186
SIC: 2833 Medicinal Chemicals & Botanical Products